Johannes C. Hellmuth

4.4k total citations · 1 hit paper
26 papers, 1.6k citations indexed

About

Johannes C. Hellmuth is a scholar working on Infectious Diseases, Immunology and Neurology. According to data from OpenAlex, Johannes C. Hellmuth has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Immunology and 5 papers in Neurology. Recurrent topics in Johannes C. Hellmuth's work include COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Johannes C. Hellmuth is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Johannes C. Hellmuth collaborates with scholars based in Germany, United States and France. Johannes C. Hellmuth's co-authors include Tobias Herold, Michael von Bergwelt‐Baildon, Brian J. Lipworth, Matthias Klein, Vindi Jurinović, Tobias Weinberger, Andreas Schmidt, Simon Rothenfußer, Sheng Cui and Karl‐Peter Hopfner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Johannes C. Hellmuth

25 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19

2020 687 citations Tobias Herold, Vindi Jurinović et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johannes C. Hellmuth Germany	15	814	495	487	363	234	26	1.6k
Melanie Zuo United States	7	1.3k 1.6×	612 1.2×	738 1.5×	523 1.4×	148 0.6×	7	2.1k
Sebastian Dolff Germany	24	649 0.8×	146 0.3×	887 1.8×	281 0.8×	247 1.1×	106	2.1k
Pak K. Hui China	12	800 1.0×	236 0.5×	216 0.4×	231 0.6×	196 0.8×	14	1.4k
Andrew Weber United States	6	825 1.0×	377 0.8×	514 1.1×	324 0.9×	110 0.5×	10	1.3k
Zhanju Liu China	11	595 0.7×	284 0.6×	245 0.5×	160 0.4×	112 0.5×	26	1.3k
Ram Doolman Israel	21	746 0.9×	89 0.2×	219 0.4×	408 1.1×	92 0.4×	54	1.8k
Adam Rupert United States	25	891 1.1×	79 0.2×	464 1.0×	204 0.6×	126 0.5×	66	2.1k
Eli Magen Israel	22	360 0.4×	106 0.2×	337 0.7×	105 0.3×	64 0.3×	91	1.4k
Aditya K. Panda India	21	321 0.4×	71 0.1×	394 0.8×	240 0.7×	188 0.8×	99	1.3k

Countries citing papers authored by Johannes C. Hellmuth

Since Specialization

Citations

This map shows the geographic impact of Johannes C. Hellmuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes C. Hellmuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes C. Hellmuth more than expected).

Fields of papers citing papers by Johannes C. Hellmuth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes C. Hellmuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes C. Hellmuth. The network helps show where Johannes C. Hellmuth may publish in the future.

Co-authorship network of co-authors of Johannes C. Hellmuth

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes C. Hellmuth. A scholar is included among the top collaborators of Johannes C. Hellmuth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes C. Hellmuth. Johannes C. Hellmuth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muenchhoff, Maximilian, Johannes C. Hellmuth, Clemens Scherer, et al.. (2024). CD74 is a functional MIF receptor on activated CD4+ T cells. Cellular and Molecular Life Sciences. 81(1). 296–296. 21 indexed citations

Vielhauer, Jakob, Johannes C. Hellmuth, Maximilian Muenchhoff, et al.. (2023). How to exclude pulmonary embolism in patients hospitalized with COVID-19: a comparison of predictive scores. Thrombosis Journal. 21(1). 51–51. 3 indexed citations

Wratil, Paul R., Alexander Graf, Stefan Krebs, et al.. (2023). Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation. Infection. 52(3). 847–855. 1 indexed citations

Pich, Dagmar, Manuel Albanese, Paul R. Wratil, et al.. (2022). Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test. PNAS Nexus. 1(2). 5 indexed citations

Knösel, Thomas, Sandra E. Hasmann, Clemens Scherer, et al.. (2022). Thyroidal Angiotensin-Converting Enzyme 2 Protein Expression and Thyroid Function Tests in Patients with COVID-19: Results from a Retrospective Case Series and a Prospective Cohort Study. Thyroid. 33(2). 177–185. 5 indexed citations

Hellmuth, Johannes C., Nikolaus Kneidinger, Marion Frankenberger, et al.. (2022). Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(2). 166592–166592. 9 indexed citations

Weckbach, Ludwig T., Johannes C. Hellmuth, Maximilian Muenchhoff, et al.. (2021). Myocardial Inflammation and Dysfunction in COVID-19–Associated Myocardial Injury. Circulation Cardiovascular Imaging. 14(1). e012220–e012220. 59 indexed citations

Munker, Dieter, Tobias Veit, Pontus Mertsch, et al.. (2021). Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection. 50(1). 157–168. 29 indexed citations

Bertlich, Mattis, Enzo Lüsebrink, Johannes C. Hellmuth, et al.. (2021). The course of subjective and objective chemosensory dysfunction in hospitalized patients with COVID-19: a 6-month follow-up. European Archives of Oto-Rhino-Laryngology. 278(12). 4855–4861. 14 indexed citations

10.

Hellmuth, Johannes C., Maximilian Muenchhoff, Clemens Scherer, et al.. (2021). Left and right ventricular dysfunction in patients with COVID-19-associated myocardial injury. Infection. 49(3). 491–500. 44 indexed citations

11.

Weber, Sabine, Johannes C. Hellmuth, Clemens Scherer, et al.. (2021). Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut. 70(10). 1925–1932. 54 indexed citations

12.

Rausch, Lisa, Martina Schifferer, Elena Winheim, et al.. (2021). Binding of phosphatidylserine‐positive microparticles by PBMCs classifies disease severity in COVID‐19 patients. Journal of Extracellular Vesicles. 10(14). e12173–e12173. 26 indexed citations

13.

Doane, Ashley S., Chi-Shuen Chu, Dafne Campigli Di Giammartino, et al.. (2021). OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity. Nature Immunology. 22(10). 1327–1340. 10 indexed citations

14.

Herold, Tobias, Vindi Jurinović, Brian J. Lipworth, et al.. (2020). Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. Journal of Allergy and Clinical Immunology. 146(1). 128–136.e4. 687 indexed citations breakdown →

15.

Chu, Chi-Shuen, Johannes C. Hellmuth, Rajat Singh, et al.. (2020). Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage. Molecular Cell. 80(5). 845–861.e10. 20 indexed citations

16.

Eichenauer, Dennis A., Annette Plütschow, Stefanie Kreissl, et al.. (2017). Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group. The Lancet Oncology. 18(12). 1680–1687. 70 indexed citations

17.

Fritsch, Susanne, Dušan Prevalšek, Nicole Engel, et al.. (2015). Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma. Bone Marrow Transplantation. 50(5). 679–684. 16 indexed citations

18.

Borchmann, Peter, Dennis A. Eichenauer, Annette Pluetschow, et al.. (2015). Targeted Beacopp Variants in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study. Blood. 126(23). 580–580. 13 indexed citations

19.

Schmidt, Andreas, Tobias Schwerd, Johannes C. Hellmuth, et al.. (2009). 5′-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proceedings of the National Academy of Sciences. 106(29). 12067–12072. 325 indexed citations

20.

Pippig, Diana A., Johannes C. Hellmuth, Sheng Cui, et al.. (2009). The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA. Nucleic Acids Research. 37(6). 2014–2025. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact